Biologics Contract Development & Manufacturing Organization Market revenue to hit USD 39 Billion by 2036, says Research Nester
February 08, 2024 05:30 ET
|
Research Nester
New York, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The global biologics contract development & manufacturing organization (CDMO) market size is projected to grow at a CAGR of over ~12% from 2024 to...
Prefilled Syringes Market Size to Surpass USD 72.9 Billion by 2033 Owing to the Increasing Prevalence of Chronic Diseases
January 22, 2024 13:30 ET
|
Market.Us
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Prefilled Syringes Market size is forecasted to exceed US$ 72.9 Billion by 2033, with a promising CAGR of 12.3% from...
Biologics Market Size Estimated to Reach USD 620.31 Billion by 2032
January 08, 2024 11:15 ET
|
Precedence Research
Ottawa, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The global biologics market size accounted for USD 387.73 billion in 2024, grew to USD 409.84 billion in 2025 and the industry is expanding at a CAGR of 6%...
Biologics Market Growth CAGR 6.9% During 2023-2032 | Xcellent Insights
January 03, 2024 03:00 ET
|
XCELLENT INSIGHTS LLP
Pune, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The global biologics market is expected to register a rapid revenue CAGR of 6.9% during the forecast period. This growth can be attributed to factors such...
Atopic Dermatitis Drugs Market Size Worth USD 25.20 Billion in 2032 | Emergen Research
December 28, 2023 08:04 ET
|
Emergen Research
Vancouver, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The global atopic dermatitis drugs market size was USD 6.10 Billion in 2022 and is expected to register a rapid revenue CAGR of 15.2% during the forecast...
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
December 07, 2023 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Second Quarter Revenue of $25.4 Million -- -- Signed $35 Million in Net New Business Orders Resulting in a Backlog of $199 Million -- -- Entered into Partnership with California...
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
November 30, 2023 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BCLI
November 26, 2023 21:36 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)...
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
November 08, 2023 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Asia-Pacific Anti-inflammatory Therapeutics Market to Reach $40.5 Billion by 2032 With CAGR of 5.4%: Says Allied Market Research
November 05, 2023 18:55 ET
|
Allied Market Research
Wilmington, Delaware, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Asia-Pacific Anti-inflammatory Therapeutics Market, By Drug Class (Biologics, NSAIDs,...